FDA Drug Chief Resigns Amid Ethics and Lawsuit Controversies
TL;DR
George Tidmarsh, head of the FDA's Center for Drug Evaluation and Research, resigned amid ethics concerns and a lawsuit alleging bribery and false statements, following his administrative leave after raising issues about a drug approval program and questioning a drug's safety.
- US FDA's drug division chief resigns amid ethics concerns and lawsuit Reuters
- F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Company The New York Times
- FDA Official Steps Down, Sued by Drugmaker The Wall Street Journal
- Top drug regulator resigns, sued after post criticizing a treatment The Washington Post
- Top FDA official quits amid inquiry into ‘serious concerns’ over his conduct The Guardian
Want the full story? Read the original reporting
Read on Reuters